Parent Educational Program for Children With Sickle Cell Disease
Primary Purpose
Hemoglobin SC Disease, Anemia, Sickle Cell
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Parent Educational Support
Sponsored by
About this trial
This is an interventional supportive care trial for Hemoglobin SC Disease focused on measuring Sickle Cell Disease, Educational Outcomes, Neurodevelopmental Functioning
Eligibility Criteria
Inclusion Criteria:
- Children with either HbSS (sickle cell anemia) or HbSβ-thal (hemoglobin S beta thalassemia) who are between 6 and 12 years of age
- Child's parent or primary caregiver agrees to participate in the study
Exclusion Criteria:
- Child is monolingual in a language other than English and cannot complete standardized testing in English
- Parent or caregiver of the child is not fluent in English or Spanish
- Child has some other developmental disability not related to SCD. This would include Down's syndrome, autism, pervasive developmental disability, cerebral palsy, seizure disorder, consequences of severe prematurity, or a documented closed head injury that resulted in loss of consciousness.
- Child has been diagnosed with a significant mental health disorder that is not responsive to behavioral or medical management. This includes severe depression, schizophrenia, or bipolar disorder. Children whose mental health problem is effectively treated are eligible for participation.
Sites / Locations
- Mailman Center for Child Development
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Annual Parent Intervention (API) Group
Quarterly Parent Intervention (QPI) Group
Arm Description
Participants in this group will receive the parent educational support intervention once a year for 2 years.
Participants in this group will receive the parent educational support intervention quarterly (4 times a year) for 2 years.
Outcomes
Primary Outcome Measures
Academic achievement as measured by the Woodcock Johnson Tests of Achievement, Third Edition
Performance on standardized measure of academic achievement, M=100, SD=15
Secondary Outcome Measures
Child's emotional and behavioral functioning, parental stress, and family functioning
Standardized parent report quesionnaires of child adjustment, parent stress, and family function
Full Information
NCT ID
NCT00860782
First Posted
March 10, 2009
Last Updated
July 26, 2021
Sponsor
University of Miami
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
1. Study Identification
Unique Protocol Identification Number
NCT00860782
Brief Title
Parent Educational Program for Children With Sickle Cell Disease
Official Title
Parent Intervention to Improve Academic Success in Children With Sickle Cell Disease
Study Type
Interventional
2. Study Status
Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
August 2008 (Actual)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Children with sickle cell disease (SCD) are at risk for central nervous system (CNS) complications, which may affect academic achievement. This study will evaluate an educational support program for parents that aims to improve academic achievement in children with SCD.
Detailed Description
SCD is an inherited blood disorder that is caused by an abnormal type of hemoglobin-the protein in red blood cells that carries oxygen to tissues. Symptoms include anemia, infections, organ damage, and intense episodes of pain, which are called "sickle cell crises." Children with SCD are also at risk for a variety of CNS complications, including various types of stroke and increased blood flow to the brain. These conditions affect neuropsychological performance and academic achievement. In children with SCD, there may also be a relationship between CNS complications, behavioral problems, family environment stressors, and pain symptoms. For example, children with SCD-related CNS complications have a higher risk of developing behavioral problems than children without SCD. In turn, behavioral problems are associated with high levels of family conflict and can be a significant stressor for families coping with SCD. This kind of stress can then lead to increased difficulty in dealing with SCD symptoms, particularly pain, for the child. This study will evaluate an educational support program for parents of children with SCD, conducted either once a year or four times a year, in terms of the program's effect on children's academic achievement. In addition, study researchers will also evaluate the program's effect on behavioral difficulties, pain frequency, and the family environment.
This study will enroll children with HbSS (sickle cell anemia) or HbSb-thal (hemoglobin S beta thalassemia) SCD. Parents or caregivers of participants will be randomly assigned to attend the educational support program meetings either once a year or four times a year for 2 years. The educational meetings with the parent/caregiver will be 45 minutes long and will cover the following four main areas:
Provide education regarding the learning issues often seen with children with SCD
Provide information regarding special education services in the school system and how the parent can obtain academic support for his/her child
Provide information on how to assist the child to better manage homework
Evaluate the child's current level of pain and how pain may affect school attendance
There will be three evaluation timepoints. At baseline and Year 3, children will undergo a neurodevelopmental evaluation, including academic achievement tests. The parent and child will complete questionnaires on emotional and behavioral functioning, stress levels, and family functioning. At Year 2, the children will complete academic achievement tests, and the questionnaires for the parent and child will be repeated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemoglobin SC Disease, Anemia, Sickle Cell
Keywords
Sickle Cell Disease, Educational Outcomes, Neurodevelopmental Functioning
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
73 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Annual Parent Intervention (API) Group
Arm Type
Experimental
Arm Description
Participants in this group will receive the parent educational support intervention once a year for 2 years.
Arm Title
Quarterly Parent Intervention (QPI) Group
Arm Type
Experimental
Arm Description
Participants in this group will receive the parent educational support intervention quarterly (4 times a year) for 2 years.
Intervention Type
Behavioral
Intervention Name(s)
Parent Educational Support
Intervention Description
Parents will attend 45-minute educational sessions that will focus on providing them with information regarding SCD and how they can best help their child perform better in school.
Primary Outcome Measure Information:
Title
Academic achievement as measured by the Woodcock Johnson Tests of Achievement, Third Edition
Description
Performance on standardized measure of academic achievement, M=100, SD=15
Time Frame
Measured at baseline and Years 2 and 3
Secondary Outcome Measure Information:
Title
Child's emotional and behavioral functioning, parental stress, and family functioning
Description
Standardized parent report quesionnaires of child adjustment, parent stress, and family function
Time Frame
Measured at baseline and Years 2 and 3
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children with either HbSS (sickle cell anemia) or HbSβ-thal (hemoglobin S beta thalassemia) who are between 6 and 12 years of age
Child's parent or primary caregiver agrees to participate in the study
Exclusion Criteria:
Child is monolingual in a language other than English and cannot complete standardized testing in English
Parent or caregiver of the child is not fluent in English or Spanish
Child has some other developmental disability not related to SCD. This would include Down's syndrome, autism, pervasive developmental disability, cerebral palsy, seizure disorder, consequences of severe prematurity, or a documented closed head injury that resulted in loss of consciousness.
Child has been diagnosed with a significant mental health disorder that is not responsive to behavioral or medical management. This includes severe depression, schizophrenia, or bipolar disorder. Children whose mental health problem is effectively treated are eligible for participation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Armstrong, PhD
Organizational Affiliation
University of Miami
Official's Role
Study Director
Facility Information:
Facility Name
Mailman Center for Child Development
City
Miami
State/Province
Florida
ZIP/Postal Code
33131
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Following final data analysis and dissemination, the SAP and ICF will be shared with investigators requesting these materials.
Learn more about this trial
Parent Educational Program for Children With Sickle Cell Disease
We'll reach out to this number within 24 hrs